Moreover, a statistical trend was observed for detrimental outcome when patients with RET fusion-driven solid tumors were treated with ICI compared to other regimens.
← all excerpts
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs".
1
—
—